Seriously? You're looking for an OTC to prove itself via fins and filings? There are plenty of NASDAQ companies that can't even do that. I get your point, but it's a bit extreme for an OTC, IMO. That's fine.
Dave OWNS Las Vegas and the surrounding areas with his product that he started. I'm fairly certain that's measurable and in my book worth acknowledging. He's growing his base in southern CA and has begun slow expansion in other regions (including abroad), with limited resources (as you said). If people read the business plan, he clearly has very conservative expectations and is already hitting some targets. I'm okay with that. For more expansion, we're probably going to see more debt and perhaps dilution. We'll see. That's not going to help perception of filings or shareholder value. However, expansion and big deals will help with momo and shareholder confidence....It all depends how one defines and values these topics. I'm not looking to nominate Dave for CEO of the year. All I said was that people do not give him enough credit, compared to other OTC CEOs who don't waste time with reverse splits, numerous toxic financing deals, dilution out the @$$, insider share deals, and the list goes on. Dave has tried harder than most OTC CEOs to protect the company and shareholders from those typical OTC tactics. We'll see how long he can keep those approaches to a minimum.
"Proving it" is subjective, and I suppose we have different perspectives on that. Fair enough. I'm simply expressing my opinion in this instance.